Cataract as a protein condensation disease: The Proctor lecture

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 10, 1997, Pages 1911-1921

  Benedek, George B ^a,b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENS PROTEIN; PANTETHINE; PHOSPHOROTHIOIC ACID S (3 AMINO 2 HYDROXYPROPYL) ESTER;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; CATARACT; CATARACTOGENESIS; CONFERENCE PAPER; GALLSTONE; HUMAN; LIGHT SCATTERING; MULTIPLE MYELOMA; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; RAT; SICKLE CELL ANEMIA;

AGING; ANIMALS; AWARDS AND PRIZES; CATARACT; CRYSTALLINS; DISEASE MODELS, ANIMAL; FLORIDA; HUMANS; LENS, CRYSTALLINE; OPHTHALMOLOGY; SOCIETIES, SCIENTIFIC;

EID: 0030954844     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)

1. Shakespeare W. Sonnet No. 16. Shakespeare's Sonnets.
2. Thurston GM, Hayden DL, Burrows P, et al. Quasielastic light scattering study of the living human lens as a function of age. Curr Eye Res. 1997;16:197-207.
3. Benedek GB, Chylack LT Jr., Libondi T, Magante P, Pennett M. Quantitative detection of the molecular changes associated with early cataractogenesis in the human lens using quasielastic light scattering. Curr Eye Res. 1987;6:1421-1432.
4. Einstein A. Theorie der opalescenz von homogenen Flussigkeiten und Flussigkeitgemischen in der Nahe des kritischen Zustandes. Annalen der Physik. 1910; 33:1275-1298.
5. Benedek GB. Theory of transparency of the eye. Appl Optics. 1971;10:459-473.
6. Spector A, Freund T, Li LK, Augusteyn RC. Age-dependent changes in the structure of a crystallin. Invest Ophthalmol. 1971;10:677-686.
7. Jedziniak JA, Kinoshita JH, Yates EM, Hocker LO, Benedek GB. On the presence and mechanism of formation of heavy molecular weight aggregates in human normal and cataractous lenses. Exp Eye Res. 1973; 15:185-192.
8. Harding J. Cataract: Biochemistry, Epidemiology and Pharmachology. London: Chapman and Hall; 1991.
9. Tanaka T, Benedek GB. Observation of protein diffusivity in intact human and bovine lenses with application to cataract. Invest Ophthalmol. 1975;14:449-456.
10. Benedek GB. Molecular basis of cataract formation. In: Nugent J, Whelan J, eds. Human Cataract Formation: CIBA Foundation Symposium 106. London: Pitman Publishers Ltd; 1984:237-247.
11. Tanaka T, Ishimoto C, Chylack LT Jr. Phase separation of a protein-water mixture in cold cataract in the young rat lens. Science. 1977;197:1010-1012.
12. Ishimoto C, Goalwin P, Sun ST, Nishio I, Tanaka T. Cytoplasmic phase separation in galactosemic cataract in lenses of young rats. Proc Natl Acad Sci USA. 1979;76: 4414-4419.
13. Tanaka T, Rubin S, Sun ST, Nishio I, Tung W, Chylack LT Jr. Phase separation in rat lenses cultured in low glucose media. Invest Ophthalmol Vis Sci. 1983;24:522-525.
14. Clark JI, Giblin FJ, Reddy VN, Benedek GB. Phase separation in x-irradiated lenses of rabbit. Invest Ophthalmol Vis Sci. 1982;22:186-190.
15. Clark JI, Carper D. Phase separation in lens cytoplasm is genetically linked to cataract formation in the Philly mouse. Proc Natl Acad Sci USA. 1987;84:122-125.
16. Broide ML, Berland CR, Pande J, Ogun O, Benedek GB. Binary-liquid phase separation of lens protein solutions. Proc Natl Acad Sci USA. 1991;88:5660-5664.
17. Pande J, Ogun O, Nath C, Benedek GB. Suppression of phase separation in bovine γ IV crystallin solutions: Effect of modification by charged vs. uncharged polar groups. Exp Eye Res. 1993;57:257-264.
18. Pande J, Lomakin A, Fine B, Ogun O, Sokolinski I, Benedek GB. Oxidation of the γ II crystallin solutions yields dimers with a high phase separation temperature. Proc Natl Acad Sci USA. 1995;92:1067-1071.
19. Kubo R. Statistical Mechanics. Amsterdam: North Holland; 1965.
20. Taratuta V, Holschback A, Thurston GM, Blankschtein D, Benedek GB. Liquid-liquid phase separation of aqueous lysozyme solutions: Effects of pH and salt identity. J Phys Chem. 1990;94:2140-2144.
21. Eaton WA, Hofrichter J. Sickle cell hemoglobin polymerization. Adv Prot Chem. 1990;40:63-279.
22. Selkoe DJ. Alzheimer's disease - A central role for amyloid. J Neuropath Exp Neurol. 1994;53:438-447.
23. Stevens FJ, Solomon A, Schiffer M. Bence Jones Proteins: A powerful tool for the fundamental study of protein chemistry and pathology. Biochemistry. 1991; 30:6803-6805.
24. Donovan JM, Carey MC. Physical-chemical basis of cholesterol and pigment gallstone formation. Gastrenterol Clin North Am. 1991;20:47-66.
25. Pande J, Berland C, Broide M, Ogun O, Melhuish J, Benedek GB. Suppression of phase separation in solutions of bovine γIV-crystallin by polar modification of the sulfur-containing amino acids. Proc Natl Acad Sci USA. 1991;88:4916-4920.
26. Eaton WA, Hofrichter J. The biophysics of sickle cell hydroxyurea therapy. Science. 1995;268:1142-1143.
27. Kupfer C. The Bowman lecture: The conquest of blindness: a global challenge. Trans Ophthalmol Soc UK. 1985;104:1-10.
28. c protein aggregates in yB crystallin solutions. Curr Eye Res. 1996;15:1182-1190.
29. ClarkJI, Benedek GB. The effects of glycols, aldehydes and acrylamide in phase separation and opacification in the calf lens. Invest Ophthalmol Vis Sci. 1980;19:771-776.
30. Hammer P, Benedek GB. The effect of naturally occurring cellular constituents on phase separation and occurring cellular constituents on phase separation and opacification in calf lens nuclear homogenates. Curr Eye Res. 1983;12:809-814.
31. Siezen RJ, Coppin CM, Benedek GB. Permanent suppression of phase separation cataract in calf lens using amine modification agents. Biochem Biophys Res Comm. 1985;133:239-247.
32. Keefe AD, Newton GL, Miller SL. A possible prebiotic synthesis of pantetheine, a precursor to coenzyme A. Nature. 1995;373:683-685.
33. Fisher DH, Thurston, GM, Ogun O. Interaction of pantethine with bovine yB crystallin. ARVO Abstract #4054. Invest Ophthalmol Vis Sci. 1995;36:S884.
34. Hiraoka T, Clark JI, Li XY, Thurston GM. Effect of selected anti-cataract agents on opacification in the selenite cataract model. Exp Eye Res. 1996;62:11-19.
35. Clark JI, LiveseyJC, SteeleJE. Delay or inhibition of rat lens opacification using pantethine and WR-77913. Exp Eye Res. 1996;62:75-84.
36. Hiraoka T, Clark JI. Inhibition of lens opacification during the early stages of cataract formation. Invest Ophthalmol Vis Sci. 1995;36:2550-2555.
37. Bursell SE, Magnante P, Chylack LTJ. In-vivo use of quasi-elastic light scattering spectroscopy as a molecular probe in the anterior segment of the eye. In: Masters B, ed. Noninvasive Diagnostic Techniques in Ophthalmology. New York: Springer-Verlag; 1990:342-365.
38. Van Laethem M, Babusiaux B, Neetens A, Clauwaert J. Photon correlation spectroscopy of light scattered by eye lenses in in-vivo conditions. Biophys J. 1991; 59: 433-444.
39. Katsura S, Sasaki K, Shibata T. In-vivo observation of crystalline lens changes in the early post-vitrectomy stage. Acta Soc Ophthalmol Jpn. 1992;96:664-669.
40. Dhadwal HS, Ansari RR, Della Vecchia MA. Coherent fiber optic sensor for early detection of cataractogenesis in a human eye lens. Opt Eng. 1993;32:233-238.
41. Dierks K, Wegener A, Diekmann M, Niederstrasser D, Schwartz R. Protein size resolution in human eye lenses by dynamic light scattering measurements correlated to Scheimpflug densitometry data. ARVO Abstract #2876. Invest Ophthalmol Vis Sci. 1995;36:S625-S625.
42. Hockwin O, Sasaki K, Lerman S. Evaluating cataract development with the Scheimpflug camera. In: Masters B, ed. Noninvasive Diagnostic Techniques in Ophthalmology. New York: Springer-Verlag; 1990:342-365.
43. Magno BV, Datiles MB III, Lasa MSM. Progression of lens opacities in cataract patients after one year. Acta Ophthalmol Scand. 1995;73:45-49.
44. Datiles MB III, Magno BV, Freidlin V. Study of nuclear cataract progression using the National Eye Institute Scheimpflug system. Br J Ophthalmol. 1995;79:527-534.
45. Magno BV, Freidlin V, Datiles MB III. Reproducibility of the NEI Scheimpflug cataract imaging system. Invest Ophthalmol Vis Sci. 1994;35:3078-3084.
46. Magno BV, Lasa MSM, Freidlin V, Datiles MB III. Comparison of linear, multilinear and mask micro-densitometric analyses of Scheimpflug images of the lens nucleus. Curr Eye Res. 1994;13:825-831.
47. Chylack LT Jr, Rosner B, Cheng HM, McCarthy DM, Pennett M. Sources of variance in the objective documentation of human cataractous change with Topcon SL45 and Neitz-CTR retroillumination photography and computerized image analysis. Curr Eye Res. 1987;6:1381-1390.
48. Fujisawa K, Sasaki K. Changes in light scattering intensity of the transparent lenses of subjects selected from population-based surveys depending on age: Analysis through Scheimpflug images. Ophthalmol Res. 1995;27: 89-101.
49. Sparrow JM, Brown NAP, Shun-Shin GA, Bron AJ. The Oxford modular cataract image analysis system. Curr Eye Res. 1990;4:638-648.
50. West S, Rosenthal F, Newland HS, Taylor HR. Use of photographic techniques to grade nuclear cataracts. Invest Ophthalmol Vis Sci. 1988;29:73-77.
51. Chylack LT, Leske ME, Khu P, Kashiwagi T, Sperduto R. Lens opacities classification system II (LOCSII). Arch Ophthalmol. 1989;107:991-997.
52. Chylack LTJ, Wolfe JK, Singer DM, et al. The lens opacities classification system III. Arch Ophthalmol. 1993;111:831-836.
53. Taylor HR, West SK. The clinical grading of lens opacities. Aust N Z J Ophthalmol. 1979;17:81-86.
54. Klein BEK, Dlein R, Lindon KLP, Magli YL, Neider MW. Assessment of cataracts from photography in the Beaver Dam eye study. Ophthalmology. 1990;97:1428-1433.
55. Sparrow J, Bron AJ, Ayliffe W, Hill AR. The Oxford clinical cataract classification and grading system. Int Ophthalmol. 1986;9:207-225.